View Older Stories View More Recent Stories

May 22, 2015 10:25AM Notable Analyst Rating Changes 5/22: (RWLK) (BAH) (DOV) Upgraded; (GD) (JGW) (CONN) Downgraded
May 22, 2015 08:16AM NV5 Holdings (NVEE) Prices 1.43M Common Offering at $19.50/Share
May 22, 2015 08:15AM NV5 Prices Underwritten Public Offering of Common Stock
May 22, 2015 07:38AM Roth Capital Affirms Trina Solar (TSL) at 'Buy'; Q1 Results Show Core Strength of Manufacturing Business
May 22, 2015 06:21AM Roth Capital Starts Vascular Biogenics Ltd (VBLT) at Buy
May 21, 2015 04:29PM NV5 Announces Proposed Public Offering of Common Stock
May 21, 2015 03:01PM Roth Affirms BlurBird (BLUE) at 'Buy'; Prelim. SCD Data at High-End of Expectations
May 21, 2015 11:25AM WSJ Article Comparing Sarepta (SRPT) and BioMarin (BMRN) 'Juvenile and Uninformed', Roth Capital Says
May 21, 2015 10:37AM Notable Analyst Rating Changes 5/21: (SSYS) (VOD) (CHTR) Upgraded; (WBAI) (SRPT) (JASO) Downgraded
May 21, 2015 09:37AM Roth Lifts PT on Regeneron (REGN) to $495 Following Sarilumab Phase 3 Results in RA
May 21, 2015 08:56AM Wave Systems (WAVX) Prices 7.3M Units Offering for Proceeds of $4.7M
May 21, 2015 08:55AM Wave Announces Pricing of Public Offering
May 21, 2015 06:40AM Roth Capital Starts Darling International (DAR) at Buy
May 21, 2015 06:38AM Roth Capital Resumes Cempra, Inc. (CEMP) at Buy
May 21, 2015 06:36AM Roth Capital Downgrades JA Solar Holdings Co., Ltd. (JASO) to Neutral
May 20, 2015 05:19PM Wave Systems (WAVX) Announces Common, Warrants Offering
May 20, 2015 05:05PM Wave Announces Public Offering
May 20, 2015 04:01PM Ideal Power Inc. Announces Closing of Underwritten Public Offering of Common Stock
May 20, 2015 06:23AM Sarepta Therapeutic (SRPT) PT Raised to $45 at Roth Capital
May 19, 2015 11:32PM Interactive Intelligence Has Priced $150 Million in Convertible Senior Notes
May 19, 2015 01:29PM bluebird bio (BLUE) PT Raised to $192 at Roth Capital
May 19, 2015 11:10AM Roth Affirms BioBlast Pharma (ORPN) at 'Buy' Following Q1 Report; U.S. Phase II/III HOPEMD Enrollment Remains Next Milestone
May 19, 2015 08:47AM Roth Capital Downgrades Radiant Logistics (RLGT) to Neutral
May 19, 2015 08:46AM Roth Capital Reiterates Buy on Green Plains (GPRE) Following Green Plains Partners (GPP) Public Prospectus Release
May 19, 2015 07:40AM Canadian Solar (CSIQ) PT Raised to $46 at Roth Capital Despite Disappointing Investor Day
May 18, 2015 03:35PM Roth Affirms Regeneron (REGN) at 'Neutral'; Dupilumab Success in Asthma Largely Priced-in
May 18, 2015 12:03PM Streetinsider.com's Hot Lunchtime Reads 5/18: (AAPL) (FB) (PLT) (ANIP)
May 18, 2015 10:55AM ANI Pharmaceuticals (ANIP) PT Lowered to $60 at Roth Capital
May 18, 2015 10:10AM Roth Remains Positive on Concert Pharma (CNCE) Amid Upcoming AVP-786 Phase 3s (AVNR)
May 18, 2015 09:31AM Pre-Open Stock Movers 05/18: (ANN) (ASNA) (SGYP) Higher; (EBIO) (TSLA) (ENDP) Lower (more...)
May 18, 2015 08:59AM Roth Capital Reiterates Buy Following Pioneer Power (PPSI) Q1 Results
May 18, 2015 08:24AM Roth Capital Starts Biodel (BIOD) at Buy, $5 PT
May 18, 2015 08:03AM Roth Capital Previews bluebird bio (BLUE) Ahead of EHA Abstract
May 18, 2015 07:52AM Roth Capital Sees Compelling Opportunities Ahead for uniQure BV (QURE)
May 15, 2015 09:10AM The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Update
May 15, 2015 08:21AM Ideal Power (IPWR) Prices 1.94M Common Offering at $7.75/Share
May 15, 2015 08:19AM Ideal Power Inc. Prices Underwritten Public Offering of Common Stock
May 14, 2015 05:05PM Ideal Power (IPWR) Announces Common Stock Offering
May 14, 2015 05:01PM Ideal Power Inc. Announces Proposed Public Offering of Common Stock
May 14, 2015 10:19AM Roth Capital Affirms Ligand Pharma (LGND) Following Positive SAGE-547 Update (SAGE)
May 14, 2015 08:58AM Roth Capital Impressed by Trecora Resources (TREC) After Site Visit
May 14, 2015 08:51AM Roth Capital Remain Bullish Leading up to Canadian Solar (CSIQ) Investor Day
May 14, 2015 07:42AM Roth Capital 'Focus Pick' on TG Therapeutics (TGTX) Reiterated Amid ASCO Data
May 14, 2015 07:22AM Argos Therapeutics (ARGS) Nearing Complete Enrollment in the Phase III ADAPT Study, Roth Capital Notes
May 14, 2015 07:19AM Roth Capital Reiterated Bullish Stance on Aduro Biotech (ADRO) Following ASCO Abstracts
May 14, 2015 06:51AM Roth Capital Raises Price Target Following Hackett Group's (HCKT) Q1 Results
May 13, 2015 01:35PM Diamondback Energy (FANG) PT Raised at Roth Capital Despite EPS Miss
May 13, 2015 12:25PM Roth Capital Reiterates Buy Following Clean Diesel Technologies (CDTI) Q1 Results
May 13, 2015 11:40AM Roth Affirms Clean Diesel Tech (CDTI) at 'Buy'; HDD, Catalyst Performing Well
May 13, 2015 10:12AM Roth Capital Remains Bullish Following Eco-stim Energy Solutions (ESES) Q1 Results
View More Recent Stories View Older Stories